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RESEARCH ARTICLE
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Regulates Muscle Stem Cell Fate
Roméo Sébastien Blanc,a Gillian Vogel,a Xing Li,b Zhenbao Yu,a Shawn Li,b
Stéphane Richarda
Terry Fox Molecular Oncology Group and Segal Cancer Center, Bloomﬁeld Center for Research on Aging, Lady
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ABSTRACT Quiescent muscle stem cells (MSCs) become activated in response to
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T

issue regeneration is a dynamic process requiring the presence of resident adult
stem cells capable of long-term quiescence and rapid activation in response to
injury. Skeletal muscle stem cells (MSCs), also called satellite cells, promote regeneration following damage of their supporting cells, the myoﬁbers. Extrinsic stimuli activate
the myogenic program leading to MSC proliferation, commitment, and differentiation
to repair the damaged ﬁber or for self-renewal to maintain the pool and preserve the
regenerative capacity. MSC loss of function leads to complete abolition of the regeneration and subsequently to loss of the skeletal muscle integrity (1).
Arginine methylation is an evolutionarily conserved posttranslational modiﬁcation
catalyzed by the protein arginine methyltransferase (PRMT) family, composed of 9
members and subdivided in three types: type I enzymes, which catalyze asymmetrical
dimethylation of the arginine guanidino group, and type II and type III enzymes, which
catalyze symmetrical dimethylation and monomethylation, respectively (2–4). Although
PRMTs have a preference for certain short motifs such as the RGG/RG motifs (5), many
PRMTs have a different substrate speciﬁcity and deviate from this motif selection. In the
past decade, the emergence of interest for arginine methylation roles has led to in vivo
studies using mouse models. Depletion of the major type I (PRMT1) in mice leads to
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skeletal muscle injury to initiate regeneration. Activated MSCs proliferate and differentiate to repair damaged ﬁbers or self-renew to maintain the pool and ensure future regeneration. The balance between self-renewal, proliferation, and differentiation is a tightly regulated process controlled by a genetic cascade involving
determinant transcription factors such as Pax7, Myf5, MyoD, and MyoG. Recently,
there have been several reports about the role of arginine methylation as a requirement for epigenetically mediated control of muscle regeneration. Here we report
that the protein arginine methyltransferase 1 (PRMT1) is expressed in MSCs and that
conditional ablation of PRMT1 in MSCs using Pax7CreERT2 causes impairment of muscle regeneration. Importantly, PRMT1-deﬁcient MSCs have enhanced cell proliferation
after injury but are unable to terminate the myogenic differentiation program, leading to regeneration failure. We identify the coactivator of Six1, Eya1, as a substrate
of PRMT1. We show that PRMT1 methylates Eya1 in vitro and that loss of PRMT1
function in vivo prevents Eya1 methylation. Moreover, we observe that PRMT1deﬁcient MSCs have reduced expression of Eya1/Six1 target MyoD due to disruption
of Eya1 recruitment at the MyoD promoter and subsequent Eya1-mediated coactivation. These ﬁndings suggest that arginine methylation by PRMT1 regulates muscle
stem cell fate through the Eya1/Six1/MyoD axis.

Molecular and Cellular Biology

embryonic lethality (6, 7), and more recently the conditional removal of PRMT1 using
Nestin-Cre has been shown to implicate asymmetrical arginine methylation in the
process of myelination (8). PRMT2-null mice were shown to be hypophagic and lean, as
STAT3 methylation is lost (9). PRMT3⫺/⫺ mice are smaller than wild-type mice, and this
hypomorphic allele has mRNA translation defects (10). CARM1/PRMT4-deﬁcient mice
have defects in adipogenesis, T cell differentiation, and hematopoiesis (11–13). PRMT5
is essential for mouse development, and whole-body genetic deletion leads to embryonic lethality (14), while conditional knockout of PRMT5 using Nestin-Cre demonstrated
a key role in regulating the p53 pathway during neurogenesis (15) and a role for PRMT5
in adult hematopoiesis maintenance was shown using Mx1-Cre (16). Mice with wholebody knockout of PRMT6 are viable; however, the mouse embryo ﬁbroblasts undergo
premature senescence (17). Type III enzyme PRMT7 (2) is required in mice for B cell
differentiation by controlling germinal center formation (18) and for muscle stem cell
regeneration (19). PRMT8-deﬁcient mice have motor coordination defects, and PRMT8
was characterized as an arginine methyltransferase and a phospholipase in Purkinje
cells (20). In humans, PRMT7 mutations were recently identiﬁed in a genetic screen and
linked to pseudohypoparathyroidism (21).
In the past few years, arginine methylation has been implicated in skeletal muscle
regeneration in vivo. CARM1/PRMT4 methylates Pax7 to regulate asymmetric division of
MSCs by recruiting the MLL1/2 complex at the kb ⫺57 enhancer of Myf5 gene (22).
Moreover, PRMT5 and PRMT7 were both shown to regulate Cdkn1a expression in a
p53-independent fashion, as arginine methylation is critical for MSC expansion and
guarding against premature senescence, respectively (19, 23). We showed that PRMT7
regulates the levels of Dnmt3b mRNA and controls DMNT3b-mediated DNA methylation of the Cdkn1a promoter region (19).
PRMT1 is responsible for generating the majority of asymmetric dimethylation of
arginine in mammals (4). Here, we performed a candidate peptide array with selective
arginine-containing peptides of key factors involved in the myogenic differentiation
and performed an in vitro methylation assay. We identiﬁed Eya1 peptides to be
methylated in vitro by PRMT1. Eya1 is a phosphotyrosine phosphatase responsible for
histone H2AX dephosphorylation during DNA repair (24). Importantly, it was shown to
interact with the transcription factors of the Six family to regulate the genetic cascade
responsible for muscle stem cell fate during myogenesis upstream of the determinant
transcription factor Pax3, therefore regulating Myf4, Myf5, Myf6, MyoG, and MyoD (25,
26). In adults, ectopic expression of the Eya1/Six1 complex is able to reprogram muscle
ﬁbers from the slow-twitch type to the fast-twitch type (27). Importantly, Six1 was
reported as a regulator of adult MSC regenerative capacity and self-renewal by modulation of MyoD and myogenin (28). The involvement of Eya1 in adult MSC physiology
remains unknown.
Here, we report that mice with a conditional deletion of PRMT1 using Pax7creERT2
exhibit decreased muscle regeneration upon cardiotoxin injury. Their MSCs displayed
defects in the myogenic differentiation program. Surprisingly, we observed that the
PRMT1-depleted MSCs had increased proliferation, suggesting augmentation of their
self-renewal capabilities. We identify Eya1 as an in vivo PRMT1 substrate. PRMT1
depletion prevented coactivation of Six1 target genes by Eya1, compromising the
activation of MyoD. Our ﬁndings deﬁne a role for PRMT1 in MSCs and a new role for
arginine methylation in MSCs.
RESULTS
PRMT1 is expressed in muscle stem cells and determines cell fate. Arginine
methylation is a key posttranslational event required for MSC regenerative function
(19). We asked whether the major type I enzyme, PRMT1, also plays a role in skeletal
muscle regeneration. To identify myogenic factors that are substrates of PRMT1, we
designed a candidate peptide array with selected candidates containing methylation
motifs in their sequence, including peptides from Pax3, Pax7, Myf5, MyoD, Myf6, Pitx2,
Six1/4, and Eya1/2, as well as proteins related to adult muscle homeostasis/regeneraFebruary 2017 Volume 37 Issue 3 e00457-16
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tion, skeletal muscle disorders, and potential substrates predicted to be methylated on
PRMT1 preferred motifs (RGG/RG and RXR motifs) (Table 1). The peptides listed in Table
2 were indeed methylated (preferred methylated motifs are in bold), and one of the top
hits was one Eya1 peptide. We focused our work on Eya1, as it is known to play a key
role in myogenesis (25). The peptide containing arginines 303, 305, 307, and 308, which
are within the evolutionarily conserved eye-absent catalytic domain of Eya1, was
methylated by PRMT1 in an in vitro methylation reaction (Fig. 1A; black arrow; peptide
2B). Eya1 is a dually speciﬁc tyrosine phosphatase and a cofactor of the Six family of
transcription factors involved in the upstream regulation of the myogenesis cascade,
including Pax3, MyoD, Myf5, MyoD, and Myf6 (25). Indeed, we conﬁrmed the arginine
methylation of Eya1 by cotransfecting FLAG epitope-tagged Eya1 with MYC epitopetagged PRMT1 in HEK293T cells. Anti-FLAG immunoprecipitations were immunoblotted
with anti-FLAG to conﬁrm Eya1 immunoprecipitation (Fig. 1B, top panels), anti-MYC
antibodies showed that PRMT1 coimmunoprecipitated with Eya1 (Fig. 1B, middle
panels), and ASYM26 showed that Eya1 was indeed asymmetrically dimethylated by
PRMT1 in cells (Fig. 1B, lower panels). Moreover, HEK293T cells were transfected with
siLuciferase (siLuc; control) or siPRMT1 and the arginine methylation of FLAG-yellow
ﬂuorescent protein (FLAG-YFP) (control) or FLAG-Eya1 monitored by anti-FLAG immunoprecipitations followed by immunoblotting with ASYM26 (Fig. 1C). FLAG-Eya1 was
methylated in siLuc-transfected cells but not in siPRMT1-transfected cells (Fig. 1C,
lowest panels).
We next examined the expression of PRMT1 in quiescent MSCs by costaining the
tibialis anterior (TA) muscle from wild-type mice with anti-Pax7 antibodies, a marker of
quiescent MSCs, and anti-PRMT1 antibodies followed by visualization by ﬂuorescence
microscopy. Pax7-positive MSCs costained with anti-PRMT1 antibodies (Fig. 2A). We next
isolated MSCs and either used them immediately or allowed them to differentiate into
mature myoblasts for 3 or 5 days. Immunostaining of the quiescent and mature
myoblasts showed that PRMT1 was expressed at all stages of differentiation with both
cytoplasmic and nuclear staining (Fig. 2B). We also observed that PRMT1 mRNA and
protein levels were at equal levels in quiescent cells (day 0) and in day 3 and 5
activated, proliferative cells and committed myoblasts (Fig. 2C and D). As controls, we
showed that MyoD protein levels were increased with differentiation, while Ponceau
red staining revealed equivalent loading (Fig. 2C).
To deﬁne the role of PRMT1 in MSCs, we generated mice that are PRMT1 deﬁcient
using a 4-hydroxytamoxifen (OHT)-inducible CRE driven by the Pax7 promoter. MSCs
were isolated following ﬁve intraperitoneal injections in PRMT1FL/FL; Pax7creERT2/⫹ and
wild-type (here designated PRMT1FL/FL; ⫺) mice, the latter being used as controls (Fig.
3A). We conﬁrmed the depletion of PRMT1 by immunostaining in Pax7-positive cells
and observed a statistically signiﬁcant decrease of Pax7⫹ PRMT1⫹ double-positive cells
(P ⫽ 0.0015) (Fig. 3B) and reduced protein methylation in PRMT1-deﬁcient MSCs (Fig.
3C). MSCs were cultured for 3 days in serum-rich medium to promote proliferation, and
we observed that following PRMT1 depletion as visualized by reverse transcriptase PCR
followed by quantitative PCR (RT-qPCR), the expression levels of Pax7 increased while
MyoD was signiﬁcantly repressed, suggesting an impairment of the myogenic differentiation (Fig. 3D). Since MyoD mRNA levels were reduced, we assessed the commitment of MSCs with immunoﬂuorescence using an anti-Myf5 antibody (Fig. 3E). Both
quiescent MSCs isolated from wild-type (PRMT1FL/FL; ⫺) and PRMT1-deﬁcient (PRMT1FL/FL;
Pax7creERT2/⫹) mice retained Pax7 expression, conﬁrming that PRMT1 did not affect
quiescent MSCs (Fig. 3E, day 0). After day 3 of culturing, wild-type (PRMT1FL/FL; ⫺)
activated MSCs entered the differentiation program, as they committed into proliferating progenitors, expressed Myf5, and aligned for fusion (Fig. 3E, second row). PRMT1deﬁcient MSCs at day 3 expressed Myf5 and not Pax7 but did not align for fusion (Fig.
3E; fourth row). These ﬁndings suggest that PRMT1-deﬁcient MSCs have differentiation
defects.
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Protein
Pax7
Pax7
Pax7
Pax3
Pax3
Myf5
MyoD
Myf6
MyoG
MyoG
FOXO1A
FOXO1A
FOXO1A
FOXO1A
FOXc2
Fgfr4
Fgfr4
Fgfr4
Fgfr4
Lbx1
Pitx2
Pitx2
Pitx2
Pitx2
Six4
Six4
Six4
Six1
Six1
Eya1
Eya1
Eya1
Eya2
Eya2
Meox2
Tbx1
Tbx1
PKM1/2
Dock7
Dock7
Dock7
Dock7
CLCN1
SmD3
Fox1
Fox1
Fox1
CUGBP
MTMR1
FASN
FASN
FASN
FASN
FASN
LaminA/C
LaminA/C
LaminA/C
LaminA/C
LaminA/C
LaminA/C
LaminA/C
LaminA/C
LaminA/C
LaminA/C
CLTC1
CLTC1

Peptide identiﬁer
1A
2A
3A
4A
5A
6A
7A
8A
9A
10A
11A
12A
13A
14A
15A
16A
17A
18A
19A
20A
21A
22A
23A
24A
25A
26A
27A
28A
29A
30A
1B
2B
3B
4B
5B
6B
7B
8B
9B
10B
11B
12B
13B
14B
15B
16B
17B
18B
19B
20B
21B
22B
23B
24B
25B
26B
27B
28B
29B
30B
1C
2C
3C
4C
5C
6C

Peptide sequence
PGMFSWEIRDRLLKDGHCD
PDLPLKRKQRRSRTTFTAEQ
QVWFSNRRARWRKQAGANQL
DLPLKRKQRRSRTTFTAEQL
QVWFSNRRARWRKQAGANQL
DRRKAATMRERRRLKKVNQA
DRRKAATMRERRRLSKVNEA
RRKAATLRERRRLKKINEA
KRKSVSVDRRRAATLREKRR
LNQEERDLRYRGGGGPQPGV
IDPDFEPLPRPRSCTWPLPR
PEGGKSGKSPRRRAASMDNN
SKFAKSRSRAAKKKASLQS
DNWSTFRPRTSSNASTISGR
FENGSFLRRRRRFKKKDVS
RLAPAGRVRGWRGRLEIASF
HGENRIGGIRLRHQHWSLVM
LPLDPLWEFPRDRLVLGKPL
KGNLREFLRARRPPGPDLSP
GKAAPGEERRRSPLDHLPPP
GAEDPSKKKRQRRQRTHFTS
ELEATFQRNRYPDMSTREE
WTNLTEARVRVWFKNRRAKW
FKNRRAKWRKRERNQQAELC
KARYTEAERARGRPLGA
VDKYRLRRKFPLPRTIW
NWFKNRRQRDRNPSETQSK
KLRGRPLGAVGKYRVRRKFP
NWFKNRRQRDRAAEAKEREN
DSERLRRGSDGKSRGRGRRN
MRKLAFRYRRVKEIYNTYKN
RGSDGKSRGRGRRNNNPSP
RPHRASDGKLRGRSKRNSDP
MRKLAFRYRRVKEMYNTYRN
HHNYLTRLRRYEIAVNLDLT
MDFVPVDDKRYRYAFHSSSW
PGALPLVSAFARSRNPVASP
RSAHQVARYRPRAPIIAVTR
VRPASLNLNRSRSLSNSN
YDFTESHNQRGRPICIAPDD
IGARQEMVRRSRGQLERSPS
SAFGSQENLRWRKDMTHWRQ
SENGGLQHRPRKDMGPRHNA
ILKAQVAARGRGRGMGRGNI
KRLHVSNIPFRFRDPDLRQM
FENSADADRAREKLHGTVVE
YRGAHLRGRGRTVYNTFRA
VYEINILRDRSQNPPQSKG
VNYYVRWNPRMRPQMPIHQN
KKVIREPRPRSARWLSTSI
LTQGEVYKELRLRGYDYGPQ
CLRKEPGGHRIRCILLSNLS
CMLGMEFSGRDRCGRRVMGL
TTAYYSLVVRGRIQRGETVL
DRLAVYIDRVRSLETENAG
ETENAGLRLRITESEEVV
KTLDSVAKERARLQLELSKV
HEELQQSRIRIDSLSAQLSQ
KLRDLEDSLARERDTSRRLL
KEREMAEMRARMQQQLDEYQ
YRKLLEGEEERLRLSPSPT
PSPTSQRSRGRASSHSSQS
VDEEGKFVRLRNKSNEDQSM
GDPAEYNLRSRTVLCGTCGQ
TDELVAEVEKRNRLKLLLPW
LLILTAIKADRTRVMEYINR

(Continued on next page)
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TABLE 1 (Continued)
Peptide identiﬁer
7C
8C
9C
10C
11C
12C
13C
14C
15C
16C
17C
18C
19C
20C
21C
22C
23C
24C
25C
26C
27C
28C
29C
30C
1D
2D
3D
4D
5D
6D
7D
8D

Peptide sequence
VTEGCDPTRVRAFGPGLEGG
CSGPGLGTGVRARVPQTFTV
RMKESITRRRQAPSIATIGS
VFGDFLGRERLGSFGSITRQ
VVYKGRHRVTGQIVAMKKI
PIIYDIRARPRKISSPTGSK
ERQLEAARYRSDGSLLLGVS
LSEVFRSRAHRDFVRDATWS
RLLGSLWRHRPDSLDNTVQ
ANQTRNERKRKKMSATHKPK
KKMSATHKPKRRRTSYGGFR
MSNLGYLRARSCWVLHAFSS
MISKRRRLDSEDKENLT
DGVTSHVSRNRATEDGEDEA
DKYWECMTTRQRPGKMTWPN
KKIQITRIMDERNRQVTFTK
RKINEDIDLMISRQRLCAVP
SIKSEPVSPPRDRTTTPSRY
DERESPSVKRMRLSEGWAT
DPNYVLSSRVRTGRSIKGYT
HPKFEEILTRLRLQKRGTGG
PPPGVSPSRLRIGDQEFDSL
TLIEPVARSRQGSGVILRQE
LPFKKGDILRIRDKPEEQWW
GPVCWRKRVKSEYMRLRQLK
KSEYMRLRQLKRFRRADEVK
KTPPKRPGGRRRGRLPNNSS
YWHLEAPSQRRLRSPNDDIS
NSHAPEEAKRSRVMGDIPVE
DLKTMSERLRNRYYVSKKLF
KKDGKKKKRSRKESY
GRGKGGKGLGKGGAKRHRKV

PRMT1 controls Six1 transcriptional activity through Eya1 recruitment. Eya1 is
the coactivator of Six1 (27, 29), and the Six1/Eya1 complex can bind and regulate MyoD
expression (30–32). We performed chromatin immunoprecipitation (ChIP) of Six1 and
Eya1 at both MyoD and Six1 promoter (Fig. 4A and B). The latter was used because it
is known that Six1 associates with its own promoter (26, 32). Eya1 binding was reduced
at MyoD and Six1 genes in the absence of PRMT1 (Fig. 4A) (P ⬍ 0.001). In contrast, Six1
binding was increased at both MyoD and Six1 genes in PRMT1-deﬁcient cells (Fig. 4B)
(P ⬍ 0.001). It was previously reported that Eya1 switches Six1-Dach activity from
repressor to activator (29). Therefore, Six1 binding is likely to be repressive without
Eya1, and indeed we observed decreased H3K4me3 at the MyoD and Six1 promoters,
consistent with gene repression (Fig. 4C) (P ⬍ 0.001).
The expression of PRMT1 and Eya1 mRNAs was examined in differentiating C2C12
cells. PRMT1 mRNA levels remained constant, while Eya1 mRNA levels decreased with
differentiation (Fig. 4D). C2C12 treated with siEya1 had differentiation defects, while
C2C12 cells transfected with siLuc did not (Fig. 4E and F). To further examine this
differentiation defect, we assessed the expression of differentiation markers by RT-

TABLE 2 Peptide array candidates methylated by PRMT1
PRMT1 substrate
Eya1
Fox1
Bml
Bml
Ash2l
Histone H4
aPreferred

Peptide sequencea
RGSDGKSRGRGRRNNNPSP
FENSADADRAREKLHGTVVE
RLLGSLWRHRPDSLDNTVQ
ANQTRNERKRKKMSATHKPK
DKYWECMTTRQRPGKMTWPN
GRGKGGKGLGKGGAKRHRKV

methylated motifs are in bold.
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Protein
Filamin-C
Filamin-C
Filamin-C
Filamin-C
Cdk1
PHB2
WDR77
WDR77
Bml
Bml
Bml
IPO8
FancD2
FancD2
Ash2l
MEF2
MEF2
MEF2
MEF2
CKM
CKM
p38
p38
p38
EZH2
EZH2
EZH2
PCAF
PCAF
PCAF
Histone H2B
Histone H4
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FIG 1 Eya1 is a PRMT1 substrate. (A) Candidate peptides were arrayed for major myogenic determinant
proteins, and the ﬁlter was incubated with recombinant GST-PRMT1 and [3H]S-adenosylmethionine for
in vitro methylation assay. The 3H-positive spots represent the methylated peptides. Peptides from
histones H2B and H4 were used as positive controls. A complete list of the peptides is found in Table 1.
(B) HEK293T cells were cotransfected with MYC epitope-tagged PRMT1 and FLAG-tagged Eya1 or
FLAG-YFP as control. Cell lysates were prepared, and immunoprecipitations were performed with
M2–anti-FLAG beads. The bound proteins were separated by SDS-PAGE and immunoblotted with
anti-FLAG, MYC, and ASYM26. TCL, total cell lysates; IB, immunoblot; IP, immunoprecipitation. (C)
HEK293T cells were transfected with siLuciferase (siLuc) or siPRMT1 for 24 h. Then, cells were transfected
with expression vectors for FLAG-Eya1 or FLAG-YFP. Cell lysates were prepared 48 h later, and coimmunoprecipitations were performed as described for panel B. See also Tables 1 and 2.

qPCR. Eya1 expression was reduced in siEya1 cells, as expected, while Myf5 was
increased and MyoD decreased (Fig. 4F). These ﬁndings show that Eya1 is required for
myogenic differentiation of C2C12, consistent with its role as a substrate of PRMT1.
Absence of PRMT1 increases muscle stem cell expansion and long-term selfrenewal but impairs differentiation. Given the role of Six1/Eya1 in myogenesis and
adult MSC self-renewal (28) and the importance for MyoD during MSC differentiation
(33), we wanted to evaluate the balance between proliferation and differentiation of
PRMT1-deﬁcient MSCs. The proliferative status of MSCs or their progeny was assessed
by scoring cells positive for anti-Pax7 and anti-Ki67 or anti-Ki67 antibodies only,
respectively. Only quiescent and self-renewing cells remain positive for anti-Pax7
immunostaining (1). We observed a signiﬁcant increase in the number of PRMT1deﬁcient MSCs that stained for Ki67 compared to wild-type MSCs at days 1, 3, and 5 of
culture (Fig. 5A and B). Actually, the majority of PRMT1-deﬁcient MSCs repressed Pax7
expression at day 3 while being Ki67 positive (Fig. 5B, blue bar), suggesting that the
absence of PRMT1 promotes proliferation. In contrast, at day 3, ⬃50% of wild-type
MSCs were mainly Pax7⫹ (Fig. 5B, white bars). After 5 days of culturing, most
wild-type MSCs were differentiated, as they had fused as multinucleated myoﬁbers and
were both Pax7 and Ki67 negative (Fig. 5B). In contrast, ⬃60% of PRMT1-deﬁcient MSCs
were Pax7⫺ Ki67⫹, suggesting that the absence of PRMT1 maintains MSCs in a
persistent proliferative state (Fig. 5B, blue bar). Notably, after 5 days in culture,
February 2017 Volume 37 Issue 3 e00457-16
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FIG 2 PRMT1 is expressed in quiescent and differentiating MSCs. (A) Immunoﬂuorescence of tibialis
anterior muscle cross-section from 6-week-old wild-type mice immunostained for PRMT1 and Pax7. The
nuclei were stained with DAPI. (B) Differentiation assay of MACS-isolated MSCs ﬁxed right after isolation
(day 0) or cultured for 3 to 5 days prior to ﬁxation, immunostained for PRMT1 and Pax7, and visualized
by ﬂuorescence microscopy. The nuclei were stained with DAPI. (C) Cell lysates were prepared from
MACS-isolated MSCs 0, 3, and 5 days in culture and immunoblotted with anti-PRMT1 or anti-MyoD.
Ponceau red staining of a band is shown to conﬁrm equivalent loading. (D) RNA was extracted from
MACS-isolated MSCs at 0, 3, and 5 days of culture, and the levels of PRMT1 were measured by RT-qPCR
and normalized to the average of GAPDH, R18S, and TBP.

PRMT1-depleted MSCs signiﬁcantly promoted the expansion of Pax7⫹ Ki67⫹ cells (P ⫽
0.467), suggesting that even in the absence of PRMT1, progenitors are capable of
self-renewal by maintaining a Pax7-positive pool of cells (Fig. 5C) (⬃12%).
As the absence of PRMT1 maintained MSCs in proliferation (Fig. 5A to C) and
decreased MyoD expression, we assumed that myogenic differentiation was compromised. Differentiation was assessed by expression of troponin T/C, and we scored the
ability of the MSC progenitors to form mature multinucleated ﬁbers. We found that
PRMT1-deﬁcient MSCs were impaired in generating fused myotubes compared with
wild-type MSCs on differentiation day 7 (Fig. 5D). The fusion index was drastically
reduced in PRMT1-null MSCs (P ⬍ 0.001), with ⬍10% of cells having 2 or 3 nuclei per
ﬁber (P ⫽ 0.007) (Fig. 5E and F). PRMT1 loss of function impairs MSC differentiation and
maintain MSCs in the proliferation and self-renewal state. Together, these results
emphasize a role for PRMT1 in the regulation of MSC cell fate decision between MSC
proliferation and differentiation.
February 2017 Volume 37 Issue 3 e00457-16
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FIG 3 PRMT1-deﬁcient muscle stem cells have myogenic defects. (A) Schematic representation of PRMT1 deletion
in MSCs and work ﬂow for MSC isolation and culturing. (B) MSCs were isolated and pooled from three PRMT1FL/FL;
Pax7CreERT2/⫹ and three PRMT1FL/FL; ⫺ mice after 4-OHT injections. The cells were cultured for 3 days in medium
supplemented with 50 nM 4-OHT prior to ﬁxation and immunostaining for PRMT1 and Pax7 and visualized by
ﬂuorescence microscopy. (C) MSC lysates after 3-day culturing were separated by SDS-PAGE, and the levels of
PRMT1-methylated proteins were determined by immunoblotting with anti-PRMT1 and ASYM26. Ponceau red
staining of a band is shown to conﬁrm equivalent loading. (D) Quantiﬁcation of PRMT1, Pax7, and MyoD mRNA
levels by RT-qPCR of the indicated MSCs 3 days after culturing. Values were normalized to the averages of GAPDH,
R18S, and TBP. (E) Representative images of MSCs immunostained for Pax7 and Myf5 from days 0 and 3 after
culturing. **, P ⬍ 0.01; ***, P ⬍ 0.001.

Mice with PRMT1-deﬁcient MSCs have muscle regeneration defects. To further
investigate the role of PRMT1 in adult MSCs in vivo, we assessed the impact of its
absence during regeneration. We injected cardiotoxin (Ctx) in tibialis anterior (TA)
muscle of mice, causing necrosis of the ﬁbers and triggering regeneration as previously
described (19). After 21 days of regeneration, we harvested the injured and uninjured
TA muscle from PRMT1FL/FL; ⫺ and PRMT1FL/FL; Pax7creERT2/⫹ mice. We ﬁrst observed a
gross size reduction of the TA from injured PRMT1FL/FL; Pax7creERT2/⫹ mice compared to
February 2017 Volume 37 Issue 3 e00457-16
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FIG 4 PRMT1 controls MyoD expression via mediation of Eya1/Six1 activity. (A) Relative (R.) levels of DNA from ChIP of Eya1
at MyoD, Eya1, and Six1 upstream promoter region (approximately bp ⫺500) normalized to input and IgG. (B) Relative levels
of DNA from ChIP of Six1 at MyoD, Eya1, and Six1 upstream promoter region (approximately bp ⫺500) normalized to input
and IgG. (C) Relative levels of DNA from ChIP of the histone mark H3K4me3 at MyoD, Eya1, and Six1 upstream promoter region
(approximately bp ⫺500) normalized to H3. (D) C2C12 cell were differentiated for days 0, 3, and 5, and the mRNA levels of
PRMT1 and Eya1 were measured by RT-qPCR and normalized to the average of GAPDH, R18S, and TBP. (E) A representative
differential interference contrast image of C2C12 cultures after transfection with siLuciferase (siLuc) or siEya1 under differentiation conditions. (F) mRNA levels of Eya1, Pax7, Myf5, and MyoD were measured by RT-qPCR and normalized to GAPDH, R18S,
and TBP in C2C12 transfected with siLuc or siEya1, harvested as undifferentiated (day 0) or after 3 days of culture in
differentiation medium (day 3). *, P ⬍ 0.05; **, P ⬍ 0.01; ***, P ⬍ 0.001; n.s., not signiﬁcant.

uninjured and PRMT1FL/FL; ⫺ muscles (Fig. 6A). Further analysis revealed an ⬃60%
reduction of the cross section area in the PRMT1FL/FL; Pax7creERT2/⫹ mice 21 days after
Ctx injection, suggesting that the muscle failed to regenerate after the necrosis induced
by Ctx (Fig. 6A and B). Regeneration was impaired, as visualized by immunoﬂuorescence, as smaller ﬁbers were observed in PRMT1FL/FL; Pax7creERT2/⫹ mice, suggestive of
a delay in the differentiation process (Fig. 6B). Interestingly, the loss of PRMT1 resulted
in an increase in Pax7⫹ cells after Ctx injury (Fig. 6C), concurring with observations in
MSC culture (Fig. 5C). Nevertheless, regeneration was impaired, supporting a requirement for PRMT1 in differentiation and maturation of the muscle progenitors. We then
indexed the postinjury regeneration at 5, 10, and 15 days following Ctx injection.
Cryosections were immunostained with embryonic myosin heavy chain, a marker of
early regeneration (Fig. 6D and E). After 5 days, muscles from both wild-type and
PRMT1FL/FL; Pax7creERT2/⫹ mice began the regeneration process, and we observed an
equal percentage of embryogenic myosin heavy chain-positive (EMHC⫹) ﬁbers from the
two sets of mice (Fig. 6D and E). After 10 days, ⬃50% of regenerating ﬁbers were
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FIG 5 Cultured PRMT1-deﬁcient MSCs display enhanced proliferation and impaired differentiation. (A)
Representative images of MSCs immunostained for Pax7 (green) and Ki67 (red) and visualized by ﬂuorescence microscopy. DAPI is blue. MSCs were cultured for 1, 3, or 5 days in proliferative medium. (B)
Quantiﬁcation of Pax7- and Ki67-positive cells as shown in panel A. For each condition, statistics were
performed based on technical triplicates and counting ⬎100 nuclei. Double-negative nuclei are not
accounted for in this analysis. WT, wild type; KO, knockout. (C) Percentages of double-positive MSCs (Pax7⫹
Ki67⫹) after day 5 culturing with the indicated genotype. (D) Representative images of MSCs immunostained for Pax7 and troponin after 7 days of culture in differentiation medium. (E) The fusion index was
calculated as the ratio of the number of myonuclei over the number of total nuclei in the ﬁeld. For each
condition, statistics were performed based on technical triplicates and counting ⬎300 nuclei. (F) Average
number of nuclei/ﬁber in each ﬁeld after MSC day 7 of differentiation. For each condition, statistics were
performed based on technical triplicates and counting ⬎300 nuclei. This represents the ratio of the number
of myonuclei over the total number of myoﬁbers present in the ﬁeld. *, P ⬍ 0.05; **, P ⬍ 0.01; ***, P ⬍ 0.001.

immature in PRMT1FL/FL; ⫺ mice versus ⬃80% in PRMT1FL/FL; Pax7creERT2/⫹ mice. Fifteen
days after Ctx injection, ⬃80% regenerating ﬁbers were EMHC⫺ in wild-type mice,
whereas ⬃80% of the ﬁbers from PRMT1-deﬁcient MSCs were EMHC⫹ (Fig. 6D and E).
These results demonstrate the requirement of PRMT1 for proper myogenic differentiation and ultimately muscle regeneration.
DISCUSSION
Muscle injury causes adult MSCs to exit quiescence and enter several rounds of
self-renewal both to ensure the maintenance of the stem cell pool and to induce
differentiation to ultimately repair damaged ﬁbers (34). In the present study, we were
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FIG 6 Adult PRMT1FL/FL; Pax7CreERT2/⫹ mice have impaired muscle regeneration following cardiotoxininduced injury. (A) (Left) Representative images of injured or uninjured tibialis anterior (TA) from
PRMT1FL/FL; Pax7CreERT2/⫹ and PRMT1FL/FL; ⫺ mice extracted 21 days after Ctx injection. The injured TA
muscles were cryosectioned at the cross-section area (CSA) (lower images, top left corner), which was
measured using nine mice of each genotype. White bar, 100 m; black bar, 1 cm. (Right) For each mouse,
ﬁve cross sections were analyzed and the average was calculated to be representative of the samples. (B)
The injured TA muscles of the indicated genotypes were cryosectioned, freshly ﬁxed, and immunostained
for Pax7 and laminin to assess regeneration. (C) (Left) Quantiﬁcation of the Pax7-positive cells per ﬁber after
regeneration in PRMT1FL/FL; Pax7CreERT2/⫹ and PRMT1FL/FL; ⫺ mice TA cross sections; (right) representative
image from Pax7CreERT2/⫹ and PRMT1FL/FL; ⫺ TA section after regeneration to show a hot spot of proliferative
Pax7-positive cells. (D) Injured TA cross sections from PRMT1FL/FL; Pax7CreERT2/⫹ and PRMT1FL/FL; ⫺ mice
extracted at days 5, 10, and 15 after Ctx injection. Injured TA were cryosectioned at the cross section area and
stained for embryogenic myosin heavy chain (EMHC) to index regeneration. For each time point, three mice
of each genotype were used. (E) Quantiﬁcation of the EMHC-positive and -negative regenerating ﬁbers in
PRMT1FL/FL; Pax7CreERT2/⫹ and PRMT1FL/FL; ⫺ TA cross sections. For each time point, three mice of each
genotype were used. For each sample, analysis was performed using the average of positive/negative EMHC
ﬁbers from three pictures to be representative of the sample. **, P ⬍ 0.01; ***, P ⬍ 0.001.

interested in deﬁning a role for PRMT1 in the modulation of MSC fate. We observed that
PRMT1 did not affect the quiescence or activation of the MSCs but was required for the
control of cell expansion and MSC fate decisions, since PRMT1-deﬁcient MSCs repressed
MyoD expression and had enhanced proliferation. Mice with PRMT1-null MSCs disFebruary 2017 Volume 37 Issue 3 e00457-16
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played an important skeletal muscle regeneration failure. Despite the regeneration
impairment, we found that absence of PRMT1 in MSCs promoted their expansion
during regeneration but repressed their differentiation. In searching for PRMT1 substrates, we identiﬁed the coactivator of Six1, Eya1, as a substrate. Eya1-deﬁcient C2C12
cells had differentiation defects associated with MyoD repression. Taken together, these
data suggest that methylation of Eya1 is required for proper muscle differentiation and
muscle regeneration.
The decision for MSCs to self-renew, enter into proliferation, or return to quiescence
is driven by complex gene networks and epigenetic events (35) that are still not fully
understood. It is, however, well established that epigenetic programs govern a vast
panel of biological processes, including tissue regeneration, stem cell differentiation,
and aging (36). Since these events are heritable from the mother cells to the daughter
cells and can be triggered by both internal and external cellular signals (37), it is fair to
assume that they are essential for the stem cell fate decision and critical for the balance
between MSC proliferation and differentiation. PRMT1 was reported as a critical regulator of hematopoietic stem cell fate decision and a key mediator of their self-renewal
(38).
We report that Eya1 is a substrate of PRMT1. Eya1 is a phosphatase and a cofactor
of the Six gene family (27, 29). Six proteins are required to drive myogenesis, as they
regulate the expression of genes upstream of the myogenic regulatory factor genes,
including MyoD (25, 26). Eya1/Eya2 double knockout mice are muscle-less, while Eya1
or Six1 mutants have strong myogenesis impairment (25). In adults, Eya1 has not been
actively studied, but its requirement for Six1 expression was shown to be responsible
for muscle progenitor fate decision from slow- to fast-twitch ﬁber (27, 39). Importantly,
it was shown that during organogenesis, Eya1 acts as a Six1 coactivator by interacting
with Six1 and switching Six1 from repressor to activator (39). Following PRMT1 depletion, we observed a decrease in known Six1/Eya targets, MyoD and Six1 mRNAs, as well
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MATERIALS AND METHODS
Animal generation and experiments. All animal studies were performed according to approved
protocols by the McGill University Animal Care Committee. The PRMT1 conditional allele has been
previously described by Yu et al. (6). These mice were backcrossed for ⬎10 generations in the C57BL/6
background before interbreeding to obtain PRMT1FL/FL homozygotes. For the generation of MSC-speciﬁc
deletion, PRMT1FL/FL mice were bred with the inducible mouse model, Pax7CreERT2 (44). Once the proper
genotype was obtained, the mice were treated with a daily dose of 1 g/25 g of 4-hydroxytamoxifen
(OHT) for 5 days. Deletion of PRMT1 was veriﬁed by mRNA and protein analysis.
For regeneration experiments, TA muscles were injected with 10 l of a solution of 10 M Ctx. For
injury studies, TA muscles were harvested and frozen in isopentane cooled in liquid nitrogen and stored
at ⫺80°C prior to sectioning. At the same time, abdominal muscles and diaphragm were extracted for
MSCs using magnetically activated cell sorting (MACS)-based isolation.
Tissue culture and transfection. Myoblast progenitor C2C12 cells were cultured in Dulbecco
modiﬁed Eagle medium (DMEM) containing 20% (vol/vol) fetal bovine serum (FBS) and 1% (vol/vol)
penicillin-streptomycin. Once C2C12 cells reached conﬂuence, differentiation was induced in DMEM
supplemented with 2% FBS. HEK293T cells were cultured in DMEM containing 10% FBS and penicillinstreptomycin.
Cells were transfected with small interfering RNAs (siRNAs; Dharmacon, Lafayette, CO) using Lipofectamine RNAi MAX (Invitrogen) according to the manufacturer’s instructions. Plasmid DNA was
transfected using Lipofectamine 2000 (Invitrogen).
Satellite cells were isolated from freshly extracted skeletal muscles using the satellite cell isolation kit
(Miltenyl) according to the manufacturer’s protocols.
Isolated satellite cells were cultured in serum-rich medium (39% DMEM, 39% DMEM–F-12, 20% FBS,
and 2% UtroserG [Pall Biosciences]) for proliferation experiments and in serum-low medium for differentiation experiments (DMEM–F-12 supplemented with 5% horse serum) at 37°C in a 5% CO2 humid
atmosphere.
Tissue processing, immunostaining, and microscopy. TA cryosections were ﬁxed with formalin
10% (Sigma) at room temperature for 15 min and permeabilized in cold methanol at ⫺20°C for 6 min,
except for EMHC staining, for which sections were not ﬁxed.
February 2017 Volume 37 Issue 3 e00457-16

mcb.asm.org 13

Downloaded from https://journals.asm.org/journal/mcb on 21 June 2022 by 207.136.114.76.

as a decrease in the H3K4me3 activation mark, consistent with a defect in Eya1
recruitment at these promoter regions. Because Eya1 was shown to be required for Six1
presence (39), we hypothesize a model where PRMT1-mediated methylation promotes
Eya1 recruitment at Six1 target genes. Six1 was also reported as a p53 repressor (40, 41),
suggesting that Six1 could affect directly the cell cycle progression. The absence of
Eya1 in C2C12 impaired differentiation and decreased MyoD expression, conﬁrming
that PRMT1 and Eya1 affect the same pathway.
The absence of MyoD expression in PRMT1-deﬁcient MSCs explains their differentiation defects. MyoD is a master regulator and activator of the differentiation cascade,
as it ﬁrst induces expression of p21 to promote cell cycle arrest and then activates the
expression of the differentiation termination factor myogenin (33). The absence of
PRMT1 in MSCs promoted their expansion in vivo only during regeneration. A similar
phenotype was observed by Tierney et al. (42) using Stat3-deﬁcient MSCs, which
resulted in an increase in their expansion but compromised their ability to differentiate,
affecting their regeneration properties. It was also observed that transient inhibition of
STAT3 enhances both the MSC expansion and muscle regeneration in aged muscles,
suggesting that it counteracts the functional decline of the MSCs associated with age
(42).
Recently, the role of arginine methylation in skeletal muscle regeneration has
received lots of attention. PRMT5 was shown to be required for adult MSC proliferation
but dispensable for embryonic myogenesis (23). PRMT7 depletion in MSC leads to
premature senescence and is required to preserve their regenerative and self-renewing
capacity (19). Asymmetrical dimethylation of Pax7 by CARM1 regulates self-renewal and
preserves the pool of adult MSCs (22). Now we can add PRMT1 to the list of PRMTs
involved in the control of the MSC proliferation and proper myogenic differentiation.
The challenge will be to deﬁne the synergic roles that arginine methylation plays
during MSC cell differentiation.
In conclusion, we report a role for PRMT1 in regulating several key transcription
factor required for MSC fate, including Six1 and MyoD, through arginine methylation of
Eya1. A better understanding of how to maintain MSC identity and how to control their
expansion could help develop small molecules for ex vivo MSC expansion for therapeutic purpose.
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